What is Asymchem Laboratories Tianjin Co Altman Z-Score?
Asymchem Laboratories Tianjin CoASLTY 72 Altman Z-Score is 8.63 as of Jun. 24, 2026, which is 52% below its 10-year median of 17.96. GuruFocus rates ASLTY with a GF Score™ of 72/100 and a GF Value™ of $4.52 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 935 Biotechnology companies, Asymchem Laboratories Tianjin Co ranks better than 80% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 12.58 is strong.
Asymchem Laboratories Tianjin Co has a Altman Z-Score of 8.63, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Asymchem Laboratories Tianjin Co's Altman Z-Score or its related term are showing as below:
ASLTY'
s Altman Z-Score Range Over the Past 10 Years
Min: 1.98 Med: 17.96 Max: 46.85
Current: 12.58
During the past 13 years, Asymchem Laboratories Tianjin Co's highest Altman Z-Score was 46.85. The lowest was 1.98. And the median was 17.96.
Asymchem Laboratories Tianjin Co (OTCPK:ASLTY) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asymchem Laboratories Tianjin Co Altman Z-Score Chart
ASLTY vs VRTX, REGN, ALNY: Altman Z-Score Comparison
For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asymchem Laboratories Tianjin Co Altman Z-Score vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Asymchem Laboratories Tianjin Co's Altman Z-Score falls into.
Asymchem Laboratories Tianjin Co Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Asymchem Laboratories Tianjin Co (ASLTY) has a Altman Z-Score of 8.63 as of Jun. 24, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Asymchem Laboratories Tianjin Co and its competitors. This is 52% below median its historical median of 17.96. Over the past decade, Asymchem Laboratories Tianjin Co's Altman Z-Score has ranged from 1.98 to 46.85. According to the industry distribution chart, Asymchem Laboratories Tianjin Co ranks #187 out of 935 companies in the Biotechnology industry, placing it in the top 20%.
Is Asymchem Laboratories Tianjin Co's Altman Z-Score too high?
Asymchem Laboratories Tianjin Co's current Altman Z-Score of 8.63 is 52% below median its 10-year median of 17.96. Over the past 10 years, this metric has ranged from a low of 1.98 to a high of 46.85. The Biotechnology industry median Altman Z-Score is 2.64. Asymchem Laboratories Tianjin Co's value of 8.63 is 226.9% above this industry median. Based on the distribution chart, Asymchem Laboratories Tianjin Co ranks #187 out of 935 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's Altman Z-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Asymchem Laboratories Tianjin Co ranks #187 out of 935 companies for Altman Z-Score. This places Asymchem Laboratories Tianjin Co in the top 20% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.64. Asymchem Laboratories Tianjin Co's value of 8.63 is 226.9% above this benchmark. Historically, Asymchem Laboratories Tianjin Co's own Altman Z-Score has ranged from 1.98 to 46.85 over the past decade. While the company's 10-year median is 17.96 vs. the industry median of 2.64, Asymchem Laboratories Tianjin Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Biotechnology company?
The median Altman Z-Score among Biotechnology companies is 2.64, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asymchem Laboratories Tianjin Co's current Altman Z-Score of 8.63 is 226.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Asymchem Laboratories Tianjin Co and its competitors. For the Biotechnology industry, the median Altman Z-Score is 2.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asymchem Laboratories Tianjin Co's current Altman Z-Score is 8.63, which is 52% below median its own 10-year median of 17.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.52, compared to a current price of $6.37 — trading 40.9% above its estimated fair value. The current Altman Z-Score is 8.63, which is 52% below median its 10-year median of 17.96 and 226.9% above the Biotechnology industry median of 2.64. Asymchem Laboratories Tianjin Co's overall GF Score™ is 72/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current Altman Z-Score is 8.63 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued.
The current stock price of $6.37 is trading 40.9% above its estimated GF Value™ of $4.52.
GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.
Key valuation signals for ASLTY:
Altman Z-Score: 8.63 (52% below median its 10-year median of 17.96)
GF Value™: $4.52 vs. price of $6.37 (40.9% above fair value)
Industry Position: 226.9% above the Biotechnology median (#187 of 935)
No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asymchem Laboratories Tianjin Co Business Description
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
72GF Score
Get the complete analysis for ASLTY
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASLTY has been successfully added to your 
